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Abstract 
 
Background 
 
The population of women of child-bearing age palliated with a Fontan repair is 
increasing. The aim of this study was to describe the progress of pregnancy and 
its outcome in a cohort of patients with a Fontan circulation in the United 
Kingdom (UK). 
 
Methods 
A retrospective study of women with a Fontan circulation delivering between 
January 2005 and November 2016 in ten specialist adult congenital heart disease 
centres in the United Kingdom. 
 
Results:  
50 women had 124 pregnancies, resulting in 68 (54.8%) miscarriages, two 
terminations of pregnancy, one intrauterine death (at 30 weeks), 53 (42.7%) live 
births and four neonatal deaths. Cardiac complications in pregnancies with a live 
birth included heart failure (n=7, 13.5%), arrhythmia (n=6, 11.3%) and 
pulmonary embolism (n=1, 1.9%). Very low baseline maternal oxygen 
saturations at first obstetric review were associated with miscarriage. All eight 
women with saturations of less than 85% miscarried, compared to 60 of 116 
(51.7%) who had baseline saturations of ≥ 85% (p=0.008). Obstetric and 
neonatal complications were common: preterm delivery (n=39, 72.2%), small for 
gestational age (<10th percentile, n=30, 55.6%, <5th centile n=19, 35.2%) and 
postpartum haemorrhage (n=23, 42.6%). There were no maternal deaths in the 
study period. 
 
Conclusion:  
Women with a Fontan circulation have a high rate of miscarriage and, even if 
pregnancy progresses to a viable gestational age, a high rate of obstetric and 
neonatal complications. 
 
  
Key Questions 
 
What is already known about this subject 
 
Pregnancies in women with a Fontan repair are relatively uncommon and 
characterized by high rates of cardiac, obstetric and neonatal complications.  
 
What does this study add? 
 
This is the largest multi-centre study to date of pregnancy outcomes in women 
with a Fontan repair. We show that maternal cardiac complications are relatively 
uncommon in contrast to neonatal and obstetric complications, which occur in 
the majority of pregnancies and most frequently in those with lower baseline 
maternal oxygen saturations. No association was found between anticoagulation 
strategy and obstetric outcomes, specifically, miscarriage and post-partum blood 
loss. 
 
How might this impact upon clinical practice? 
 
This study will provide clinicians with detailed and contemporary information 
upon which they can base pre-conception advice for women with a Fontan repair. 
Furthermore, our study underlines the importance of managing these women in 
specialist centres, where they will receive appropriate care from the 
multidisciplinary team.    
Introduction 
 
The Fontan circulation was devised in 1971 to separate pulmonary and 
systemic circulations in patients with complex congenital conditions 
characterized by the presence of a single functional ventricle. Its success in 
altering the natural history of these conditions means that the already 
substantial number of women with this condition in the United Kingdom (UK) 
adult population is expected to increase by around 60% over the next decade 
(1); many of them will wish to embark upon a pregnancy.  It is clear that women 
with a Fontan circulation find it difficult to support a pregnancy, probably 
because the systemic ventricle’s ability to increase its cardiac output is 
compromised by restricted preload and chronically elevated systemic venous 
pressures (2). Pregnancy also predisposes to the development of atrial 
arrhythmias (3, 4).  Prophylactic anticoagulation during pregnancy is advocated 
by some, but may exacerbate any bleeding tendency and increases the risk of 
postpartum haemorrhage (4, 5).  Those with fenestrated circuits or collateral 
vessels may have cyanosis, which is associated with increased rates of 
miscarriage and fetal complications including preterm delivery and fetal growth 
restriction (6, 7). 
Given these complications, women need comprehensive preconception 
counseling (PCC) from appropriately experienced multidisciplinary teams (MDT). 
However there are limited data to inform these discussions (4). The aim of this 
study was to define pregnancy outcomes from a UK cohort of patients with single 
ventricle physiology palliated with Fontan repair. 
  
Methods 
Study Population 
All UK specialist centres providing a joint obstetric and adult congenital heart 
disease (CHD) service were emailed in September 2016 and invited to contribute 
data on women with a Fontan circulation who had been pregnant. Pseudo-
anonymized data was collected through review of medical and obstetric case 
notes. The study period was January 2005 to November 2016.  
 
Data Collection 
Demographic and baseline maternal data included underlying cardiac anatomy, 
surgical repair, presence of fenestration, age at Fontan completion, history of 
arrhythmia or thrombo-embolic events, New York Heart Association class 
(NYHA), oxygen saturations, anticoagulation regime and qualitative 
echocardiographic assessment of ventricular function and atrioventricular valve 
regurgitation. Cardiac Disease in Pregnancy Risk scores (CARPREG) were 
calculated for all women (8).   
 
Complications were classified as maternal cardiac, obstetric or neonatal. 
Maternal cardiac complications included arrhythmia, heart failure requiring 
treatment, systemic thromboembolism, development of new cyanosis (resting 
maternal saturations <92%) and protein losing enteropathy. Obstetric 
complications included pregnancy induced hypertension (PIH, >140mmHg 
systolic or >90mmHg diastolic after 20 weeks gestation); pre-eclampsia (PIH 
with proteinuria >0.3g per 24 hour urine collection), HELLP syndrome 
(haemolysis, elevated liver enzymes and low platelets); preterm delivery 
(delivery <37 weeks gestation); postpartum haemorrhage (PPH) (blood loss 
≥500ml at vaginal delivery and ≥1000mls at caesarean section).  Neonatal 
complications included preterm birth (<37 weeks gestation), small for 
gestational age (corrected fetal birthweight <10th centile and <5th centile)(9, 10); 
stillbirth (fetal demise ≥24 weeks gestation); neonatal death (death within first 
month of birth); occurrence of congenital heart disease.  
 
Statistics 
Data were analysed using SPSS V.23 for Windows. Continuous variables were 
expressed as medians, range and interquartile range (IQR). Correlations were 
calculated using Pearson’s product moment if variables were continuous and 
Spearman rank-order correlation if either of the variables was ordinal. 
Differences between continuous variables was assessed with the Mann–Whitney 
U test as they were not normally distributed. Categorical data was expressed as 
absolute numbers and percentages of the denominator and compared using 
Fisher's exact test or the χ2 test if cell numbers were too large. All tests were 
two-tailed and p<0.05 was considered statistically significant. 
 
Ethics 
Collection of identifiable data previously recorded as part of routine clinical care 
was restricted to members of the clinical team caring for the women. Meta-
analysis was limited to data provided without patient identifiers 
(pseudoanonymisation) and therefore this study did not require ethical approval 
(UK National Research Ethics Committee recommendation). 
 
 
Results 
Study Population 
Of fourteen centres contacted, twelve agreed to participate but two subsequently 
withdrew due to inability to retrieve necessary clinical information. 50 women 
had 124 pregnancies. 17 women (34%) had one pregnancy, 11 (22%) had two, 
15 (30%) had three, two (4%) had four, three (6%) had five, one (2%) had eight 
and one (2%) had nine. Thirteen (26%) women had no viable pregnancies, 26 
(52%) had one, seven (14%) had two, three (6%) had three and one (2%) had 
four. There were 53 (42.7%) livebirths in 37 women. In addition, there were 68 
(54.8%) miscarriages (63 (92.6%) of these were in the first trimester and five 
(7.3%) second trimester), two terminations, one intrauterine death at 30 weeks 
gestation and four (3.2%) neonatal deaths. Median age at first pregnancy was 27 
years (range 19-36 years, interquartile range (IQR) 24 to 29 years). Underlying 
congenital heart lesions and type of Fontan repair are shown in Table 1. Median 
age at Fontan repair was 7 years (range 1-26 years, IQR 4-12 years). Maternal 
baseline characteristics are shown in Table 2. 42 women (84%) were white 
European, eight (16%) were South Asian. Median body mass index at first 
pregnancy was 25 (range 18-39, IQR 23-28). Two women smoked pre-pregnancy.  
 
Preconception counseling 
96 (77.4%) of all pregnancies were planned and 41 (82%) of women had 
received PPC prior to their first pregnancy. Of the 12 women whose first 
pregnancy was unplanned, only four (33%) women had had PCC. Both women 
who chose a first trimester termination had had PCC 
 
Medication  
Prior to pregnancy  
Table 3 shows cardiac medications prescribed prior to pregnancy in all 53 
pregnancies resulting in livebirths. 
 
Anticoagulation and antiplatelet use during pregnancy. 
Anticoagulant and antiplatelet regimens were individualized and involved 
multidisciplinary decision. In 86 (70.5%) of the 122 pregnancies for which we 
have medication data, women were taking warfarin pre-pregnancy and one, 
continued to take warfarin until the third trimester (late presentation). All others 
stopped warfarin on becoming pregnant. In the 52 of 53 cases where women had 
a livebirth and anticoagulation details were available, one (1.9%) took no 
medication (booked late at 29 weeks), two (3.8%) took aspirin alone, two (3.8%) 
took a prophylactic dose of low molecular weight heparin  (LMWH) (clexane 
40mg, dalteparin 5000IU or tinzaparin 4500IU - based on booking weight (11)), 
12 (23.1%) took prophylactic LMWH and aspirin, 24 (46.2%) took treatment 
dose LMWH (clexane twice daily or dalteparin twice daily, based on booking 
weight, with poor compliance in two cases) and 11 (21.2%) took treatment dose 
LMWH and aspirin. Women taking treatment dose LMWH had Factor Xa levels 
performed in accordance with their local guidance. One patient was converted 
back to warfarin following development of a subchorionic haematoma and 
recurrent vaginal bleeding felt to be exacerbated by treatment dose LMWH; she 
ruptured her membranes at 24 weeks and delivered at 26 week with suspected 
chorioamnionitis. 
 
Infertility 
Three women, underwent in vitro fertilization for unexplained infertility (all had 
a prior miscarriage). None conceived following in vitro fertilization; one went on 
to have a successful pregnancy from a spontaneous conception. 
 
Miscarriage 
68 (54.8%) of pregnancies ended in miscarriage. Maternal baseline saturations 
at the first obstetric visit (typically 8-12 weeks) were associated with 
miscarriage; all eight women with baseline saturations less than 85% miscarried, 
compared to 60 of 116 women (51.7%) with saturations greater than or equal to 
85% (Fisher’s exact, p=0.008). No significant correlation with miscarriage 
frequency was seen at saturations greater than or equal to 85% (p = 0.595, 
Spearman’s rank correlation test). The five second trimester (≥14 weeks) 
miscarriages were all associated with recurrent early pregnancy bleeding; 
subsequently developing   a subchorionic haematoma. All women took LMWH (3 
prophylactic dose and two treatment dose). It is notable that the median initial 
haemoglobin concentration in pregnancies ending in miscarriage was 144g/l 
(range 99-196g/dl, IQR 130-160g/l) whereas in pregnancies with a live birth it 
was 138g/l (range 109-161g/dl, IQR 130-150g/dl)(Spearman correlation, 
p=0.05). This is substantially higher than in normal pregnancies (mean value 
120 SD 7.0 at 12 weeks of pregnancy), the high values likely being a consequence 
of maternal cyanosis (12). We did not find any correlation between oxygen 
saturation or haemoglobin concentration and birth weight centile (Pearson’s 
correlation coefficients 0.030 and 0.059, p values 0.831 and 0.672 respectively). 
In women with a documented fenestration prior to pregnancy there were 13 
potentially viable births from 22 pregnancies (59%) compared with 41 of 102 
(40.2%) women without fenestrations (p=0.145). 
 
Cardiovascular complications in pregnancies progressing beyond 24 weeks 
Analyzing both the CARPREG and NYHA score at the beginning of each 
pregnancy, neither was useful in predicting miscarriage, or birthweight and 
gestational age in pregnancies with a successful outcome (Spearman correlation, 
p=0.453 and 0.536; p=0.707 and 0.746 and p=0.444 and 0.854 respectively). 
Maternal heart failure was the most common cardiovascular complication 
encountered, occurring in seven women, all required diuretics. The majority (six 
out of seven) were asymptomatic pre-pregnancy with only one of these requiring 
early delivery (33 weeks by caesarean section) because of worsening symptoms, 
three required inpatient care. One patient, NYHA Class II at the onset of 
pregnancy deteriorated to NYHA Class IV by 19 weeks gestation and required 
inpatient care until delivery. 
 Six pregnancies were complicated by arrhythmia. Arrhythmia during 
pregnancy was more common if there was a prior history (five out of six with 
prior history vs one out of 48 with no prior history, p<0.0001 by Fisher’s exact 
test). Only one of the five women who had a documented prior arrhythmia had a 
previous ablation. One patient had atrial fibrillation at 15 weeks and following 
delivery; both episodes were treated with cardioversion. One patient was treated 
with amiodarone for supraventricular tachycardia prior to delivery. Ten women 
had at least one documented episode of hypoxemia that developed for the first 
time during pregnancy.  
Postnatally one woman developed multiple pulmonary emboli early in 
the postpartum period, associated with poor compliance with LMWH.  There 
were no cases of protein losing enteropathy prior to or during pregnancy.  
 
Obstetric complications 
Median gestation at live birth was 33.5 weeks (range 25-40 weeks, IQR 30-37 
weeks). Delivery occurred before 37 weeks in 38 of 53 (71.7%) cases.  In 14 of 
38 (30.2%) cases this was due to spontaneous preterm labour. 13 of 38 (24.5%) 
babies were delivered preterm for fetal reasons and 11 of 38 (20.8%) for 
combined fetal and maternal indications. 12 out of 53 births (22.6%) were 
spontaneous vaginal delivery, 10 women (18.9%) had an assisted vaginal 
delivery and 31 (58.5%) were delivered by caesarean section (12 elective, 19 
emergency). 
Median blood loss in the 53 livebirths was 750mls (range 160-3000mls, 
IQR 500-1200mls). It exceeded 500ml (classified as a PPH) in 23 (43.4%) cases.  
Blood loss was lowest with spontaneous vaginal delivery (n=13, median 600mls, 
range 200-2500mls, IQR 300-1450mls) and elective caesarean section (n=12, 
median 600mls range 300-1000mls, IQR 500-788mls). It was higher following 
assisted vaginal delivery (n=10, median 875mls range 200-2500mls, IQR 525-
1975mls) and emergency caesarean section (n=19, median 800mls range 160-
3000mls, IQR 600-1800mls). Major obstetric hemorrhage (blood loss >2000mls) 
occurred in 7 women. There was no relationship between the use of 
anticoagulation regimes and postpartum blood loss. 
Two pregnancies were complicated by pre-eclampsia, with cases of PIH or 
HELLP.  
 
Neonatal Complications 
39 (72.2%) babies were born before 37 weeks, 11 of 39 (28.2%) following pre-
labour rupture of membranes. 32 of 39 (82.1%) required admission to a 
neonatal unit secondary to immaturity. 30 out of 54 (55.6%) babies were small 
for gestational age (<10th centile) with 19 out of 53 (35.2%) <5th centile. The 
median birth weight centile was nine (n=54, range 1-74, IQR 4-25). There was 
one stillbirth at 30 weeks gestation (thought secondary to severe fetal growth 
restriction). There were four neonatal deaths of babies born at: 26 weeks 
(birthweight centile 4), 27 weeks (birthweight centile 15), 31 weeks 
(birthweight centile 2) and 31 weeks (birthweight centile 16).  All had 
respiratory distress syndrome and two had necrotizing enterocolitis. No babies 
had CHD. 
 
Cardiac complications at follow up. 
Four women defaulted from follow-up after pregnancy. Follow-up data were 
available for 39 pregnancies in 33 women (median follow-up was 6 years, range 
4 months to 10.4 years,). There was no observed decline in ventricular function 
or atrio-ventricular valve regurgitation, and no maternal deaths at last follow up. 
Two women required cardioversion after pregnancy for recurrent atrial 
arrhythmias (at four and six years respectively) with one women undergoing 
revision of her Fontan with a modified right atrial MAZE.  
 
 
Discussion 
 
In this cohort of women with a Fontan circulation, the majority of those who 
conceived and went on to have a livebirth did not encounter serious maternal 
cardiac complications. This is likely to be because women who fail to conceive, or 
who conceived and subsequently miscarried, have a more advanced physiology 
with lower oxygen saturations. It is, also, almost certainly indicative of the 
successful provision of a specialized multi-disciplinary approach to the 
management of this complex group. 
  Although the majority of women in our cohort were NYHA class I or had a 
CARPREG score of 0 or 1 (86%) pre-pregnancy, we observed a high rate of 
miscarriage, obstetric and neonatal complications. The background rate of 
miscarriage in women with a clinically apparent pregnancy, but without heart 
disease is 20% (13). The rate of miscarriage in our study was 56%. This is 
double the rate of miscarriage in women with most other forms of  congenital 
heart disease (14) and similar to the high rates of miscarriage (>40%) reported 
in large series of women who had cyanotic heart disease (15). Presbitero et al 
demonstrated that the high rate of miscarriage in women with cyanotic heart 
disease relates to lower maternal oxygen saturations and higher baseline 
maternal haemoglobin concentrations (15). It may be that the high rate of 
pregnancy complications is related to an adverse effect of the Fontan circulation 
on the venous circulation in the pelvis. Interestingly, within our cohort 24% (13 
of 54) of women had a fenestrated Fontan of which the majority had saturations 
of <92%.  Whilst cyanosis has a demonstrated association with miscarriage, 
which we also found in this cohort, the impact of a fenestration in the Fontan 
circulation is less clear and from our results does not appear to adversely affect 
the likelihood of achieving a viable pregnancy. The relationship between 
cyanosis and fenestration is complex as there are other causes for cyanosis in the 
Fontan circulation such as collateral formation.  
  
Reassuringly most women had PCC although the nature of this will vary 
between centres. This is higher than a recent study that examined rates of PCC in 
women with heart disease (16) . Whilst maternal events were low in our cohort, 
consideration should be given at the time of PCC as to whether elective ablation 
in the context of prior arrhythmia or, more controversially, strategies to optimise 
saturations should be considered for women with Fontan circulations embarking 
on pregnancy. 
 Obstetric events were common, with 72% of women delivering pre-term 
with 44% of these births due to spontaneous preterm labour. Spontaneous 
preterm labour is commoner in women with heart disease, but this is poorly 
understood (17, 18).  Median birth weight centile was nine suggesting that most 
babies were growth restricted as well as being born preterm. Small for 
gestational age babies are commoner in women with CHD, but the degree of 
growth restriction in our series is greater than reported in other forms of heart 
disease(19). Kapman et al linked cardiac disease with abnormal placentation, 
demonstrating abnormal uteroplacental Doppler flow studies in women with 
pre-pregnancy cardiac dysfunction (20, 21). Serial growth scans are indicated 
from 24 weeks gestation due to the significantly increased risk of SGA.  
 
PPH was more common than expected with an overall rate of 43%. 
Previously, we have shown that women with a Fontan circulation have a greater 
risk of PPH than women with other cardiac lesions (22). In 13% of deliveries 
(seven of 54) women had a major obstetric haemorrhage (blood loss>2000mls). 
Blood loss at delivery was lowest with spontaneous vaginal delivery, which is 
consistent with data from the Registry on Pregnancy and Cardiac Disease 
(ROPAC) (23). However, blood loss was greatest in women who underwent an 
assisted vaginal delivery, largely as a result of perineal trauma (24). Since many 
women with a Fontan circulation maybe advised to have a shortened second 
stage (25), the rate of assisted vaginal delivery may contribute to the higher rate 
of PPH. Interestingly, blood loss did not correlate with the anticoagulation 
regimen.  
The preferred strategy for anticoagulation is controversial; the concern of 
thromboembolic complications secondary to the pro-thrombotic combination of 
the Fontan circulation and pregnancy. Currently there is no consensus on which 
anticoagulation regime to give (26). Using aspirin and warfarin outside of 
pregnancy reduces the incidence of thromboembolic events although it remains 
unclear which strategy is optimal (27). Since both a Fontan circulation and 
pregnancy are pro-thrombotic conditions, it would seem reasonable to use 
anticoagulants to reduce this risk, however the evidence is consensus opinion. 
Finally, there remains significant uncertainty and unease with regards to the 
long-term impact of pregnancy upon the Fontan circulation. 
 
Limitations 
Our study was retrospective so is susceptible to missing data. Under-reporting of 
miscarriage and termination of pregnancy is likely. Our cohort is limited to 
women who were NYHA class I or II, with no women with protein losing 
enteropathy. This may be due to these women being counseled against 
pregnancy, or because they fail to conceive.  Our study was multicenter and there 
was no standardized practice for managing this group of women in pregnancy. 
We are therefore unable to draw conclusions with regards to the long-term 
impact of pregnancy upon women with the Fontan circulations. We have been 
able to comment on associations found to be significant but there may be some 
relevant associations that were not apparent in our study simply by chance 
because of the relatively small numbers of patients on whom we had data.  
 
Conclusion 
 
Women who conceive with a Fontan circulation and particularly those who have 
low oxygen saturations have high rates of miscarriage. Those that do not 
miscarry are more likely to encounter obstetric and neonatal complications; in 
particular higher rates of preterm delivery, fetal growth restriction and PPH. 
Adverse cardiac events are relatively uncommon when women are managed in a 
specialized multi-disciplinary setting.  
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